Jee Y. Chung

FDA investigator

Appears on 5 documents from 2013 to 2023, most often at sites in Massachusetts. Most often cites written procedures; deviations (21 CFR 211.100).

5
Documents on file
4.4
Observations per 483
2013
First seen
2023
Most recent

What they cite most

From 22 observations

Activity by year

2013: 1, 2017: 1, 2019: 2, 2023: 1

Where

Massachusetts 2 · California 1 · Maryland 1 · North Carolina 1

Is Jee Y. Chung coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 FUJIFILM Diosynth Biotechnologies U.S.A., IncFeb 10, 2023 · North Carolina
483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCJan 18, 2019 · Andover, Massachusetts
483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCJan 17, 2019 · Andover, Massachusetts
483 Amgen, IncMay 16, 2017 · Thousand Oaks, California
483 Human Genome Sciences, Inc.Apr 26, 2013 · Rockville, Maryland

About this profile

What does Jee Y. Chung inspect?

Jee Y. Chung appears on 5 documents on file covering 4 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.160 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jee Y. Chung is dated Feb 10, 2023.

FDA Investigator Jee Y. Chung: 483s & Inspections · FDA Intel